These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 11183564)

  • 21. Recurrent thromboembolism in ovarian cancer.
    Fuglsang J; Ingerslev J; Havsteen H
    Acta Obstet Gynecol Scand; 2004 Dec; 83(12):1218-20. PubMed ID: 15548160
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparison of ximelagatran with warfarin for the prevention of venous thromboembolism after total knee replacement.
    Francis CW; Berkowitz SD; Comp PC; Lieberman JR; Ginsberg JS; Paiement G; Peters GR; Roth AW; McElhattan J; Colwell CW;
    N Engl J Med; 2003 Oct; 349(18):1703-12. PubMed ID: 14585938
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Post-thrombotic syndrome, recurrence, and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 months.
    Schulman S; Lindmarker P; Holmström M; Lärfars G; Carlsson A; Nicol P; Svensson E; Ljungberg B; Viering S; Nordlander S; Leijd B; Jahed K; Hjorth M; Linder O; Beckman M
    J Thromb Haemost; 2006 Apr; 4(4):734-42. PubMed ID: 16634738
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The battle of the clot.
    Mandell BF
    Cleve Clin J Med; 2009 Feb; 76(2):80. PubMed ID: 19188470
    [No Abstract]   [Full Text] [Related]  

  • 25. Anticoagulant therapy. What to consider in practical management.
    McPherson ML; Grace KA
    Adv Nurse Pract; 1997 May; 5(5):32-4, 37-9. PubMed ID: 9459911
    [No Abstract]   [Full Text] [Related]  

  • 26. Management of thromboembolism in patients with cancer.
    Viale PH
    Oncol Nurs Forum; 1999; 26(10):1625-32; quiz 1633-4. PubMed ID: 10573679
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New anticoagulants & clinical trials.
    Haideri N; Patel H
    Mo Med; 2009; 106(1):60-4. PubMed ID: 19245126
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anticoagulants: the state of the art.
    Gallus AS
    Aust Fam Physician; 1982 Jan; 11(1):14-22. PubMed ID: 7065989
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Standard-intensity vs low-dose anticoagulation for long-term management of patients with venous thromboembolism.
    Lazo-Langner A; Kovacs MJ
    Clin Adv Hematol Oncol; 2005 Nov; 3(11):877-9. PubMed ID: 16491633
    [No Abstract]   [Full Text] [Related]  

  • 30. [Recommended use of INR in the laboratory monitoring of oral anticoagulant treatment].
    Syrjälä M
    Duodecim; 1998; 114(6):573-5. PubMed ID: 11466922
    [No Abstract]   [Full Text] [Related]  

  • 31. Recurrent thromboembolism in cancer patients: incidence and risk factors.
    Prandoni P; Piccioli A; Pagnan A
    Semin Thromb Hemost; 2003 Dec; 29 Suppl 1():3-8. PubMed ID: 14730471
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coagulation, anticoagulation and pancreatic carcinoma.
    Nakchbandi IA; Löhr JM
    Nat Clin Pract Gastroenterol Hepatol; 2008 Aug; 5(8):445-55. PubMed ID: 18594494
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of combined modality prophylaxis including short-duration warfarin to prevent venous thromboembolism after total hip arthroplasty.
    Keeney JA; Clohisy JC; Curry MC; Maloney WJ
    J Arthroplasty; 2006 Jun; 21(4):469-75. PubMed ID: 16781396
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anticoagulants in venous thromboembolism.
    Fennerty A; Campbell IA; Routledge PA
    BMJ; 1988 Nov; 297(6659):1285-8. PubMed ID: 3144365
    [No Abstract]   [Full Text] [Related]  

  • 35. More on: vitamin K antagonists and cancer.
    Agnelli G; Taliani MR; Prandoni P;
    J Thromb Haemost; 2008 Aug; 6(8):1441-2; author reply 1442-3. PubMed ID: 18532996
    [No Abstract]   [Full Text] [Related]  

  • 36. A review of the practical advantages of low molecular weight heparin in the treatment of cancer-related venous thromboembolism.
    Rhodes S; Bond S
    Eur J Oncol Nurs; 2008 Dec; 12(5):425-9. PubMed ID: 18842458
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Accumulation of risk factors enhances the prothrombotic state in atrial fibrillation.
    Ohara K; Inoue H; Nozawa T; Hirai T; Iwasa A; Okumura K; Lee JD; Shimizu A; Hayano M; Yano K
    Int J Cardiol; 2008 Jun; 126(3):316-21. PubMed ID: 17689760
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management and prevention of venous thromboembolism.
    Coughlin PB; Salem HH
    Aust Fam Physician; 1990 Aug; 19(8):1249-56. PubMed ID: 2403311
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Venous thromboembolism and cancer: a two-way clinical association.
    Agnelli G
    Thromb Haemost; 1997 Jul; 78(1):117-20. PubMed ID: 9198139
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism.
    Ridker PM; Goldhaber SZ; Danielson E; Rosenberg Y; Eby CS; Deitcher SR; Cushman M; Moll S; Kessler CM; Elliott CG; Paulson R; Wong T; Bauer KA; Schwartz BA; Miletich JP; Bounameaux H; Glynn RJ;
    N Engl J Med; 2003 Apr; 348(15):1425-34. PubMed ID: 12601075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.